Superficial injury of ankle and foot, unspecified

ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S90.9 Cause of death: ICD-10 — S90.9 2 out of 7 registries used, show all original rules.	196
4. Check minimum number of events None	196
5. Include endpoints None	196
6. Filter based on genotype QC (FinnGen only)	191

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S90
Name in latin: Laesio superficialis tarsi/pedis non specificata

NAME	ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE
CONTROL_EXCLUDE	ST19_INJURI_ANKLE_FOOT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S909
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S909
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Superficial injury of ankle and foot, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	191	121	70
Unadjusted period prevalence (%)	0.04	0.04	0.03
Median age at first event (years)	40.88	39.21	43.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
196: Matched controls
1960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S90.9

ICD-10 Finland

Superficial injury of ankle and foot, unspecified

+∞

281.4

196

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

10.2

34.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.6

24.1

279

X59

ICD-10 Finland

Exposure to unspecified factor

4.5

19.9

192

W22

ICD-10 Finland

Striking against or struck by other object(s)

6.6

19.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

7.2

16.3

S93.4

ICD-10 Finland

Sprain and strain of ankle

4.6

13.1

S92.3

ICD-10 Finland

Fracture of metatarsal bone

25.0

10.4

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

4.9

10.3

N02AX02

ATC

tramadol; systemic, rectal

2.5

9.2

475

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

8.7

153

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

9.2

8.5

W19

ICD-10 Finland

Unspecified fall

3.9

7.9

X58

ICD-10 Finland

Exposure to other specified factors

2.9

7.5

153

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

6.6

120

S92.2

ICD-10 Finland

Fracture of other tarsal bone(s)

72.1

6.5

Z00.8

ICD-10 Finland

Other general examinations

3.4

6.3

NH2AA

NOMESCO Finland

Heel X-ray examination

+∞

6.3

M25.5

ICD-10 Finland

Pain in joint

2.2

6.2

410

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

6.1

217

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

391

2.13

5.62

5.3

7.1

—

(3045414) Leukocytes [Presence] in Urine

3.04

4.19

1.2

1.6

—

(3023368) Bacteria identified in Blood by Culture

315

1.99

4.14

5.6

4.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

535

1.84

4.04

13.1

9.8

1.16

1.20

inr

0.18

186

(3042936) Bacteria identified in Isolate by Culture

175

2.22

4.00

1.7

1.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

538

1.78

3.69

5.0

4.4

35.88

36.56

g/l

0.52

515

(3007853) Bacteria identified in Skin by Aerobe culture

175

2.14

3.62

1.9

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

220

2.03

3.58

3.4

2.7

63.32

339.46

ng/l

1.06

145

(3002030) Lymphocytes/100 leukocytes in Blood

104

789

1.68

3.16

7.3

5.9

28.93

29.47

0.21

758

(3037467) Urinalysis macro (dipstick) panel - Urine

131

1064

1.70

3.01

3.5

4.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

10.21

2.99

1.4

3.6

113.40

131.20

—

(3037522) Nuclear Ab [Titer] in Serum

196

1.96

2.97

1.4

700.00

521.00

titre

—

(3018010) Neutrophils/100 leukocytes in Blood

102

779

1.65

2.96

6.5

5.7

56.92

56.43

0.17

745

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.44

2.84

1.4

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

246

1.84

2.83

1.6

1.3

11.29

10.46

u/ml

0.03

102

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

473

1.67

2.81

3.1

2.9

19.91

28.67

ng/l

0.62

268

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

558

1.63

2.69

6.4

5.6

1.23

1.22

mmol/l

0.58

517

(3027008) Opiates [Presence] in Urine

129

2.08

2.65

2.5

2.1

—

(3027944) Amphetamines [Presence] in Urine

130

2.06

2.60

2.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

130

2.06

2.60

2.5

2.1

—

(3019069) Monocytes/100 leukocytes in Blood

761

1.58

2.53

7.7

6.2

7.66

8.19

0.89

727

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

5.12

2.42

1.0

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

758

1.55

2.39

7.4

5.9

2.70

2.78

0.16

718

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

490

1.59

2.39

2.1

1.8

93.63

94.04

pmol/l

0.02

240

(3019198) Lymphocytes [#/volume] in Blood

105

837

1.55

2.36

6.5

5.9

2.13

1.91

e9/l

1.95

764

(3026008) Bacteria identified in Urine by Culture

421

1.61

2.34

2.3

2.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2.26

2.32

2.5

4.1

1.24

1.69

mmol/l

—

(3045424) Erythrocytes [Presence] in Urine

3.58

2.29

1.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

130

1.96

2.24

2.6

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

292

1.65

2.13

1.7

1.5

19.08

20.34

nmol/l

0.24

255

(3006315) Basophils [#/volume] in Blood

100

801

1.51

2.12

6.7

6.0

0.04

e9/l

1.15

714

(3001604) Monocytes [#/volume] in Blood

100

801

1.51

2.12

6.6

6.0

0.59

0.55

e9/l

0.92

715

(3016879) Cocaine [Presence] in Urine

118

1.97

2.12

2.7

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

254

1.67

2.02

1.5

1.2

15.20

28.46

iu/ml

0.81

(3000850) Epithelial cells [#/volume] in Urine

296

1.63

2.02

2.1

2.5

8.10

5.61

e6/l

0.53

267

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

152

1339

1.60

2.02

3.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

112

928

1.48

1.96

8.2

9.2

4.16

3.97

e9/l

0.43

104

822

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.07

1.91

2.3

3.9

86.29

72.46

ng/l

0.17

(3022096) Basophils/100 leukocytes in Blood

728

1.47

1.88

7.6

6.0

0.77

0.67

0.75

685

(3015377) Calcium [Moles/volume] in Serum or Plasma

442

1.52

1.85

2.4

3.0

2.34

2.35

mmol/l

0.37

391

(3026493) Urate [Moles/volume] in Serum or Plasma

328

1.57

1.85

2.2

2.4

329.47

2343.89

umol/l

0.78

293

(3022313) Gas panel - Capillary blood

2.25

1.82

2.2

4.4

—

(3011288) Drugs identified in Urine by Screen method

2.00

1.76

3.9

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

131

1133

1.47

1.75

7.4

6.5

75.60

74.49

u/l

0.15

124

1061

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

222

1.64

1.75

2.4

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.08

1.75

6.4

8.6

25.46

25.03

mmol/l

0.15

(3027315) Oxygen [Partial pressure] in Blood

2.99

1.74

2.0

5.0

9.11

9.60

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.99

1.74

2.0

5.0

4.86

5.08

kpa

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

457

1.49

1.73

2.2

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

207

1.65

1.71

2.4

2.8

1.10

3.38

e6/l

2.17

111

(3013707) Erythrocyte sedimentation rate by Westergren method

132

1147

1.46

1.69

5.8

3.6

12.42

9.45

mm/h

0.96

125

1054

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.58

1.69

1.6

2.3

—

(3002582) Erythrocytes [#/volume] in Urine

424

1.49

1.67

2.9

3.0

19.40

57.78

e6/l

1.70

330

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.86

1.66

1.6

1.9

—

(40768797) Stomach Pathology biopsy report

185

1.67

1.63

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

178

1.67

1.60

2.2

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2.75

1.59

1.0

1.6

1532.43

239.20

e6/l

—

(3013115) Eosinophils [#/volume] in Blood

100

834

1.41

1.56

6.9

6.2

0.19

0.18

e9/l

0.26

749

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

332

1.50

1.55

3.3

2.0

2.96

2.84

mg/l

0.12

288

(4200892) Spirometry reversibility

101

1.86

1.55

1.4

—

(3018095) Leukocytes [#/volume] in Urine

513

1.43

1.53

3.3

3.5

32.09

84.01

e6/l

0.63

351

(3022621) pH of Urine by Test strip

1.89

1.53

2.4

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.95

1.49

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

2.43

1.47

1.4

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.78

1.44

1.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

2.31

1.42

2.7

2.4

—

(3028707) Methadone [Presence] in Urine by Screen method

2.01

1.42

2.7

2.3

—

(3000991) Gas panel - Venous blood

1.82

1.40

8.8

8.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

339

1.47

1.40

1.8

1.9

0.84

0.86

mg/l

0.03

255

(3018418) pH of Serum or Plasma

384

1.44

1.39

3.1

3.3

7.41

7.40

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.99

1.36

2.2

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.03

1.36

1.6

1.5

—

(3021901) Oxygen saturation in Capillary blood

2.55

1.31

1.0

2.8

—

(3033658) Prothrombin time (PT) actual/Normal

336

1.44

1.28

5.0

3.8

92.16

94.20

0.19

331

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.10

1.24

2.7

3.3

158.60

167.69

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

166

1544

1.49

1.20

16.7

11.5

139.39

139.69

mmol/l

0.92

160

1498

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

637

1.34

1.19

6.5

6.2

1.22

1.21

mmol/l

0.55

544

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.54

1.16

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

166

1547

1.48

1.15

16.6

11.5

3.95

3.94

mmol/l

0.11

160

1495

(3021589) Normoblasts [#/volume] in Blood

716

1.33

1.15

9.2

8.8

0.01

0.00

e9/l

0.27

586

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.04

1.13

2.0

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

195

1.51

1.12

2.1

1.6

1274.41

1190.61

nmol/l

0.19

149

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.92

1.09

1.8

1.7

—

(3024928) Oxygen saturation in Venous blood

2.42

1.09

1.2

3.4

—

(3026782) Osmolality of Urine

284

1.42

1.08

2.6

2.9

524.66

561.74

mosm/kgh2o

0.50

244

(36304419) Bacteria [Presence] in Urine

383

1.37

1.07

2.8

2.9

—

(3044889) 12 lead EKG panel

110

968

1.31

1.07

2.9

3.2

—

(3019150) Specific gravity of Urine by Refractometry

348

1.38

1.05

3.4

3.3

1.01

1.02

kg/l

—

(3000492) Spirometry study

164

1.53

1.05

1.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

224

1.46

1.05

2.2

2.6

0.24

0.87

e6/l

3.90

127

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

488

1.33

1.02

3.3

3.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

124

1.59

1.01

3.8

2.5

2673.43

4998.50

u/l

—

(3030467) Casts [#/volume] in Urine by Automated count

387

1.35

1.01

2.9

3.0

0.21

0.33

e6/l

0.48

299

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.68

1.00

1.2

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

100

1.65

1.00

2.6

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

2.20

0.98

1.0

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.84

0.98

1.6

1.2

—

(3000330) Specific gravity of Urine by Test strip

1.74

0.98

1.6

3.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

170

1606

1.44

0.94

16.7

10.9

22.30

20.40

mg/l

0.30

141

1222

(3023511) Choriogonadotropin [Units/volume] in Urine

1.68

0.93

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

126

0.54

0.92

1.1

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

773

1.28

0.92

3.9

4.7

0.00

estimate

-0.00

156

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.10

0.90

1.2

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

786

1.27

0.88

3.0

3.4

0.00

estimate

-0.00

151

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

129

1.52

0.87

1.2

16.20

130.01

iu/ml

—

(3008898) HLA-B27 [Presence]

1.64

0.87

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

462

1.30

0.85

3.0

2.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.81

0.85

1.3

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

770

1.26

0.84

7.7

5.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.71

0.80

2.0

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

24.29

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.79

0.0

3.2

—

16.84

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.70

0.75

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.70

0.75

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.67

0.74

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.67

0.74

1.1

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.87

0.74

1.0

1.2

—

(1616796) Gas panel - Central venous blood

2.03

0.73

1.6

5.0

—

(3029937) Albumin [Presence] in Urine by Test strip

406

1.28

0.72

3.0

3.5

0.00

estimate

-0.00

151

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

132

1222

1.25

0.72

5.3

3.8

14.41

14.63

pmol/l

0.47

126

1117

(3019225) pH of Specimen

110

1.49

0.71

3.4

4.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

342

1.29

0.71

2.4

3.3

—

(3035350) Ketones [Presence] in Urine by Test strip

782

1.23

0.70

2.9

3.3

0.00

estimate

-0.00

162

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.67

0.70

2.3

2.1

—

(3002032) Base excess in Venous blood by calculation

120

1.46

0.67

3.5

4.8

3.41

2.35

mmol/l

0.62

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.81

0.66

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

153

1447

1.26

0.64

13.9

9.7

89.88

90.34

ml/min/173m2

0.09

132

1160

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.62

0.63

1.6

2.0

32.00

35.79

nmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.68

0.62

1.0

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

247

1.30

0.62

2.2

1.6

260000351.44

443.53

pmol/l

0.49

224

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

293

1.28

0.61

3.3

2.7

1004.46

1095.36

ng/l

0.10

230

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

615

1.21

0.61

2.8

3.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.5

—

(21494755) Public health laboratory ask at order entry panel

240

0.72

0.60

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

124

1152

1.21

0.60

3.3

2.8

37.07

39.44

u/l

0.28

119

1103

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

704

1.20

0.59

2.8

2.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

369

1.25

0.59

1.4

1.6

1.54

1.39

mmol/l

0.30

317

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

305

1.26

0.57

1.4

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.69

0.57

1.2

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.55

0.55

4.7

3.3

0.71

0.68

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.50

0.54

1.2

1.6

—

(40768804) Tissue Pathology biopsy report

583

1.20

0.54

2.0

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

202

0.72

0.53

2.0

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

365

1.23

0.52

1.9

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

153

1461

1.22

0.50

3.9

3.6

5.70

mmol/l

0.01

142

1344

(4034850) Laboratory test

1.58

0.49

18.7

8.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1.58

0.49

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.50

0.48

1.3

1.6

—

(3000494) Fungus identified in Specimen by Culture

165

1.31

0.47

1.3

1.4

—

(40768443) Skin Pathology biopsy report

1.47

0.47

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

140

1329

1.19

0.47

4.6

4.5

38.92

38.41

mmol/mol

0.21

130

1248

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

202

1.27

0.46

1.4

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

121

1.35

0.46

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.42

0.45

2.8

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

139

1.32

0.45

1.4

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.39

0.44

1.1

1.0

—

12.80

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

287

1.22

0.44

1.9

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.38

0.43

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

158

1522

1.20

0.41

4.0

3.9

2.79

2.82

mmol/l

0.19

145

1420

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

3.7

—

58.04

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(40768795) Lymph node Pathology biopsy report

0.00

0.41

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.48

0.40

1.0

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

115

1.33

0.40

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.44

0.39

1.2

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

3.57

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

169

0.75

0.39

1.8

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.40

0.38

4.8

3.4

4.01

4.46

e9/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.40

0.38

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.40

0.38

6.6

3.5

57.00

57.11

—

(4035726) Immunohistochemistry procedure

112

0.70

0.38

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.41

0.35

1.5

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

458

1.15

0.34

1.3

0.41

1.01

u/ml

2.39

131

(3020891) Body temperature

1.34

0.34

10.0

5.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

137

1.26

0.33

1.3

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

101

1.31

0.32

1.3

1.2

121.66

204.36

u/ml

0.46

(3041096) Erythrocytes [Presence] in Urine by Automated

471

1.14

0.31

2.6

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.33

0.31

1.3

2.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.31

0.30

1.3

—

16.68

—

(40761511) CBC panel - Blood by Automated count

174

1701

1.20

0.30

13.6

9.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.28

0.30

2.7

3.1

91.00

93.55

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.24

0.29

1.0

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

151

1463

1.14

0.29

6.2

4.4

1.84

1.81

mu/l

0.12

140

1354

(3036489) Thrombin time

1.30

0.28

2.4

2.8

20.25

21.63

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.28

0.28

3.3

2.1

37.38

38.55

u/l

—

(3013512) EKG study

349

1.15

0.28

2.9

3.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

0.69

0.26

5.2

7.8

24.54

24.67

mmol/l

—

(40761535) Cells panel - Urine sediment

114

1.25

0.26

2.1

3.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.71

0.24

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

136

0.80

0.24

1.2

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.26

0.22

1.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

345

1.13

0.22

2.1

—

(40768793) Breast Pathology biopsy report

1.23

0.22

1.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

68.09

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.21

0.0

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.21

0.0

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3015183) Erythrocyte sedimentation rate

0.00

0.21

0.0

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.6

—

(3025941) Bacteria identified in Stool by Culture

111

0.80

0.20

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

186

0.85

0.20

1.6

—

(3022145) Colonoscopy Study observation

146

1.18

0.20

1.6

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.18

0.19

1.3

2.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.25

0.19

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

185

0.85

0.19

1.1

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

186

1839

1.22

0.18

21.9

16.0

40.61

40.69

0.07

179

1750

(3007164) IgA [Mass/volume] in Serum or Plasma

399

1.10

0.18

1.6

1.4

2.13

g/l

0.00

256

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.74

0.17

1.0

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

766

1.07

0.16

3.1

2.7

81.32

84.53

ug/l

0.08

713

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

141

1440

0.93

0.15

3.5

3.3

1.36

1.27

mmol/l

0.58

132

1348

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.12

0.15

1.0

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

266

1.11

0.15

1.7

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.79

0.15

2.0

—

(36660697) Celiac disease serology panel - Serum

160

1.14

0.14

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

408

1.07

0.11

2.2

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.11

0.10

1.8

4.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1.11

0.10

2.8

1.6

1.80

7.54

iu/l

—

(3002256) Pathology report gross observation

175

1.09

0.09

1.1

1.2

—

(3012516) Albumin [Mass/volume] in Urine

307

0.94

0.08

3.4

3.1

40.22

79.69

mg/l

0.86

201

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.79

0.08

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

418

0.95

0.08

1.5

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

326

0.94

0.07

1.6

1.7

—

(1002224) Polysomnography panel

0.83

0.07

1.3

1.1

—

(3015736) pH of Urine

653

1.04

0.06

2.9

3.2

6.29

5.87

—

(3003694) ABO and Rh group [Type] in Blood

516

0.96

0.06

1.5

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

119

1.10

0.06

3.0

2.3

11.67

10.50

g/l

0.53

109

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

242

0.94

0.05

4.7

3.9

20.44

21.26

—

(3001019) Free T4 and TSH panel - Serum or Plasma

109

0.91

0.04

1.4

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

106

0.94

0.01

3.9

1.22

1.23

mmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

146

0.96

0.00

4.4

6.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

101

0.99

0.00

2.2

1.6

1.50

1.24

g/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

109

1.01

0.00

1.0

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

149

1494

0.99

0.00

3.7

3.6

1.39

1.46

mmol/l

0.91

139

1400

(1761868) Lipid panel - Serum or Plasma

621

1.00

0.00

2.0

2.4

—

(3016502) Oxygen saturation in Arterial blood

113

0.97

0.00

10.6

7.8

94.02

96.07

0.52

107

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

187

1.02

0.00

2.6

2.7

0.56

0.69

ug/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

325

0.98

0.00

3.8

3.6

6.98

11.37

mg/mmol

0.44

210

(46235355) HIV 1 and 2 tests - Meaningful Use set

515

1.01

0.00

2.1

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

150

1498

1.01

0.00

3.8

3.7

4.66

4.69

mmol/l

0.12

142

1409

(40761536) Microorganisms panel - Urine sediment

148

1.01

0.00

2.9

3.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

10.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

3.0

—

686.87

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

0.0

18.1

—

103.25

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.0

—

(3017704) Immunofixation for Urine

0.00

0.0

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

0.00

0.0

1.7

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

3.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

2.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.02

-0.00

1.4

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

51.00

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

264.22

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

39.40

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.90

-0.00

1.0

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1536.80

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.01

-0.00

1.0

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.02

-0.00

15.5

6.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

130

1.00

-0.00

4.3

2.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

4.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

21.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

-0.00

0.0

4.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.36

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

12.8

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

1.7

—

7.66

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.90

-0.00

1.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.90

-0.00

1.0

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.8

—

7.78

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

6.58

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

-0.00

0.0

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.90

-0.00

1.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

1.01

-0.00

1.0

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.0

—

161.77

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

-0.00

0.0

2.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE – Superficial injury of ankle and foot, unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Superficial injury of ankle and foot, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Superficial injury of ankle and foot, unspecified (ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints